Skip to main content
Premium Trial:

Request an Annual Quote

IRBM Science Park Licenses Dotmatics' Cheminformatics Suite

Premium

Dotmatics said this week that IRBM Science Park, a spinoff from Merck Research Laboratories in Rome, Italy, has licensed its bioinformatics suite to support its cheminformatics research efforts.

The suite includes tools to for structure-activity relationship analysis, chemical informatics, data capture, compound sourcing, and biochemical data management. IRBM Science Park researchers will use the solution to register, query, browse, analyze, and visualize project information.

Alberto Bresciani, head of screening technologies at IRBM Science Park, said the Dotmatics suite provides "a unified platform" that can "efficiently manage scientific data" across diverse projects.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.